chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mom reported a rash, reddened and raised "measles like" developed w/I 24hrs of immunization. Started at hairline and behind ears. Mom then called later to say she believes it was bug bites and attached pictures to an email (72 hrs after rash developed); 4 dry, crusty raised areas noted in pictures; with slightly reddened area around "crust".
Myalgia, SkinRash, Tachycardia, pruritus Narrative:
Hard time controlling fine motor movements; Arm is weaker; Fatigue easily; This spontaneous case was reported by a consumer and describes the occurrence of FINE MOTOR SKILL DYSFUNCTION (Hard time controlling fine motor movements), MUSCULAR WEAKNESS (Arm is weaker) and FATIGUE (Fatigue easily) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced FINE MOTOR SKILL DYSFUNCTION (Hard time controlling fine motor movements), MUSCULAR WEAKNESS (Arm is weaker) and FATIGUE (Fatigue easily). At the time of the report, FINE MOTOR SKILL DYSFUNCTION (Hard time controlling fine motor movements), MUSCULAR WEAKNESS (Arm is weaker) and FATIGUE (Fatigue easily) outcome was unknown.            No concomitant medications were being used.  Treatment information was not reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Pt has had 6 doses of pertussis vaccine with last dose (BOOSTRIX) 7-8-11 and still contracted pertussis.
I have HSV-2.  Outbreaks are rare.  When they occur they happen on my left buttock and in my coccyx area.  After my 2nd Moderna shot, I experienced known symptoms (slight fever, chills, body aches, headaches)  for about 12 hours beginning at about midnight on 2/10/2021.  These symptoms subsided at about 12P on 2/11.  At around 11P on 2/12, while sleeping, I felt a strange abrasion near the right corner of my mouth.  I awoke to what appeared to be a herpes sore in the corner of my mouth.  Over the next couple of hours this sore  balloned into what I would describe as a severe herpes outbreak in an area where I have never had one before.  It is a cluster of several discrete blisters at the corner of my mouth.  I am assuming since I have HSV 2 that that is what these blisters are and for some reason the vaccine triggered this response.  I wanted to report  it because a) it is in a place where I have never had an outbreak and b) I thought there might be a chance that it's not HSV 2 and that the vaccine may cause this reaction in some people.  I am treating the outbreak with famciclovir.   I am reporting this on 12/14 and the blisters are still active and underlying skin area is red/ angry. Thank you.
Pt was given a FLUZONE Intradermal vaccine. The vaccine is to be administered to pt's 18 yrs of age to 64 yrs of age. Pt is 17 yrs old. Spoke to someone - was told that there is no contraindication - to call pt and re-vaccinate pt with appropriate vaccine.
pt recv vax 2JUN97 & JUN97 pt exp fever, chills, & nausea;
BRIEF OVERVIEW: Admission Date: 8/28/2023 Discharge Date: 8/30/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dizziness [R42] Hypoxia [R09.02] Stroke-like symptoms [R29.90] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: The patient is a 73-year-old female who presented the hospital complaints of weakness.  Given the nature of patient's symptoms initial concern was for possible acute CVA.  The patient did test positive for COVID on admission and was found to be hypoxic.  CT of the head was obtained in the emergency department and without acute findings.  MRI was subsequently performed and also was negative for acute etiology.  Patient's symptoms were felt to be secondary to infectious etiology given her positive COVID status.  With Decadron the patient improvement of her respiratory status and overall symptoms.  She was additionally sent for MRI of the cervical spine given her complaints right shoulder pain and associated neuropathy.  MRI of the neck was without significant spinal stenosis.  Today the patient has been weaned to room air and is without complaints of shortness of breath.  She feels steady on her feet and his comfortable being discharged home today.  Recommendations for follow-up have been discussed with the patient and she is being discharged home today in stable condition
Achy joints and muscles, tiredness, back hurting, mild fever. I got the vaccine at about 12:15, and around 9pm I started to suddenly not feel great. I had COVID early December, and these symptoms felt similar to COVID, but less severe. Now, the next morning, I'm still not feeling great, but don't seem to have any fever.
Extremely hot and light headed immediately after vaccine was administered. Few hours later started itching all over. Still itching 2 days later.; Extremely hot and light headed immediately after vaccine was administered. Few hours later started itching all over. Still itching 2 days later.; Extremely hot and light headed immediately after vaccine was administered. Few hours later started itching all over. Still itching 2 days later.; This is a spontaneous report from a non-contactable consumer (Patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown) via an unspecified route of administration on 10Feb2021 (at the age of 50-year-old) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had known allergies. The patient did not receive any vaccines within four weeks prior to the vaccination. On 10Feb2021, on the same day of vaccination, the patient experienced extremely hot and light headed immediately after vaccine was administered. Few hours later started itching all over. Patient still itched 2 days later. The patient did not receive any treatment for the event. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of all the events was not resolved.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a physician, for the Pregnancy Registry for GARDASIL, concerning a male baby's 24 year old mother with anxiety and depression and no known allergies who on 15-OCT-2007 was vaccinated with the first dose of GARDASIL. On 14-JAN-2008 she was vaccinated intramuscularly with the second 0,5 ml dose of GARDASIL (lot no. 659055/1522U). Concomitant therapy included WELLBUTRIN. Her LMP was 07-JAN-2008. Due date was 13-OCT-2008. On approximately 17-AUG-2008 the mother delivered a baby boy "at around 32 weeks gestation, almost two months early". The physician did not remember exactly and did not have the patient's chart at her immediate disposal. The physician also followed the baby in her practice. The physician reported "he was now around nine months old and weighed around 15 pounds. He had some failure to thrive issues and had some developmental delays". No further information was provided at this time. Follow-up information received from the physician concerning that the mother had experienced prolonged premature rupture of membranes and was given intravenous PITOCIN and steroids for the baby since less that 34 weeks gestation. The baby had fetal distress in labor which the physician thought was not surprising given the age and loss of amniotic fluid, but she delivered vaginally on 27-AUG-2008, at 32+2 weeks gestation (her EDD was 13-OCT-2008). The baby had a patent foramen ovale, "which is now almost gone", and tachycardia for which he was followed by a pediatric cardiologist. "We are not worried about this though", The most concerning problem the baby had was his weight gain. The physician saw him in Mid-Jun and he only weighed 15LBS, and he was having some reflux problems for which he was sent to a pediatric gastroenterologist. The physician read from a form that the pediatric gastroenterologist consult dated 19-Mar-2009 which noted the baby was seen for his atrial-septal defect/patent foramen ovale, which was almost gone, and he had a normal echocardiogram, with recommended followed up in one or two years. the baby's patent foramen ovale were considered to be congenital anomaly. No additional information is available. The mother's adverse effects were captured in WAES# 0807USA04408. This information was previously reported in 0807USA04408.
Pt felt light headed, VS taken, Pt refused EMS, Orange juice provided, pt states she feels better, Pt released via wheelchair & nurse, spouse at side
Pt came to pharmacy and said he want to report : he experienced back pain, tiredness, sleepiness for 2 days and couple hours after receiving vaccine, he was very sleepy and he got up one time during night to get glass of water and he fainted ( he is not sure for how long) , upon coming back to conscious , he went to sleep on his bed.  he said his tiredness lasted 2 days
Hospitalized 10/13/2022 for SOB, pO2 venous 27,  venous O2 sat 51% Death report indicates patient died 10/18/2022. Immediate Cause: Covid 19 Infection  Submitter does not have access to any further medical records. If further information is needed, please contact MEDICAL CENTER
pt recvd vax  & had long periods of screaming; reported by mom; called MD; if s/s cont to er; took to er for screaming, er MD could find no apparent reason ? poss rxn to vax;
At 1:30 PM pt was weak and feverish. At 2:30 PM pt took Tylenol and went to sleep. Did not take temperature. At 5 PM felt fine.
hot flashes; hot under arm; swollen under arm with Humira; chills; hard at injection site; swollen at injection site; red at injection site; body aches/muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills) and MYALGIA (body aches/muscle aches) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills), MYALGIA (body aches/muscle aches), VACCINATION SITE INDURATION (hard at injection site), VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). At the time of the report, HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills), MYALGIA (body aches/muscle aches), VACCINATION SITE INDURATION (hard at injection site), VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) had resolved.            Concomitant medication and treatment drug were not reported.
A few days after first shot, my eyelids began to swell.  I was given desonide Ointment to rub into eyelids and they were better within a day.  It happened again after my second shot on 3/3/21 and I again use the ointment.
12-year-old patient received Pfizer peds (5-11) dose instead of the Pfizer adult dose.
Noted pruritis webs of left hand progressed to numbness up to both elbows, tongue felt funny, numbness chin and jaw line. Given Benedryl and after one hour relief of numbness, hives, wheeze, SOB, edema noted. remained stable, released.
Shot 2-Nausea; vomiting; couldn't eat or drink; headache; skin pain; This is a spontaneous report from a contactable other HCP.  A 44-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 22Jan2021 18:00 (at the age of 44 years old) at single dose for covid-19 immunisation.  Medical history included vestibular problems, allergies Cipro, migraines, concussion, all from an unknown date and unknown if ongoing.  Concomitant medication included budesonide (BUDES), levocetirizine dihydrochloride (XYZAL), montelukast sodium (SINGULAIR), nortriptyline, olopatadine.   The patient previously took cipro [ciprofloxacin] and experienced allergies. Patient also had BNT162B2 dose 1 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) lot unknown, on 02Jan2021 at 11:45 AM on left arm. The patient did not have any other vaccines in four weeks. The patient has not had covid-19 prior to vaccination. The patient experienced " Shot 2-Nausea, vomiting, headache, skin pain, couldn't eat or drink" on 23Jan2021 09:00 with outcome of recovering. The events resulted patient in Emergency room/department or urgent care. Patient was also received IV fluids, nausea medication, 2 pain medications for headache.  The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 25Jan2021.  Therapeutic measures were taken as a result of the events.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Nausea, Vomiting, and Eating disorder cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a 62 years old female patient referring to herself. Pertinent medical history and drug reactions/allergies were not reported. On 17-NOV-2015 the patient was vaccinated with 1 injection of ZOSTAVAX (dose, route, lot# and expiration date were not reported) in the left arm for prevention of shingles. Concomitant drug was not reported. After she received the vaccination, the patient felt really weak and did not sleep well on an unknown date in November 2015. In the morning of 18-NOV-2015, the patient was feeling nausea but it was easing up. Outcome of the events of feeling weak and not sleeping well was not reported. The causality was not reported. Additional information is not expected as there was no contact information.
Severe pain in the injection muscle and surrounding area for 48 hours. Arm was tender to the touch. Severe neck pain began in the left side, closest to the injection area, then spread to both sides of the neck. The neck pain lasted an entire week. Muscle fatigue, general fatigue, chills, fever, massive amount of sweating especially when trying to sleep.
A few weeks after the vaccine I developed a short-term memory loss experience where I lost two items and to date, they have never been found, but I never left my home or property, nor did I lend them out, but they have not been found still to date.  And I have not experienced that episode again.  Within two weeks of the Vaccine-2nd Event- I would all the sudden become extremely exhausted to where I would get so sleepy, out of the blue, to where I would just want to lay down anywhere no matter where I was at and just go to sleep, but I have never been much of a napper.  I still experience those from time to time, but they're not as frequent as they were initially.  After about two months I begin experiencing SOB under exertion, which progressively get a little worse as time goes on.
Hemodialysis patient received only 1 ml of Engerix-B on 19TH Oct 2022 instead of 2ml dosing; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 76-year-old male patient who received HBV (Engerix B) (batch number AC397, expiry date unknown) for prophylaxis.   Concurrent medical conditions included hemodialysis.   On 19th October 2022, the patient received Engerix B 1 ml. On 19th October 2022, unknown after receiving Engerix B, the patient experienced underdose. On an unknown date, the outcome of the underdose was unknown.   Additional Information: GSK Receipt Date: 25-Oct-2022 Reporter's comment: The clinical manager reported a hemodialysis patient received only 1 ml of Engerix-B instead of 2 ml dosing. The consent to follow-up was granted. Additional Supportive Information: The patient received only 1 ml of Engerix-B instead of 2 ml dosing, which led to underdose.
The pt experienced redness, swelling of arm to golf ball size, lightheadedness, migraine type headache. The pt called the ER for advice over the weekend.
Bad sore arm for 24 hours Possible migraine/headaches began 2-3 days later unsure if related to the vaccine. I normally don?t get migraines and it?s been lasting ever since, all day and has progressively slowly gotten worse, some very minor nausea at night from the headache. Not even Tylenol extra strength helps the pain.
Upon receiving injection, I became dizzy due to blood pressure drop. For 4 days following injection I had a severe headache. I called my Dr and they ordered a CT scan of my brain and sinuses. I developed nausea and a low grade fever which developed into a higher grade fever {100 degrees). As of the 20th of April I am still experiencing these symptoms. The CT scan came back negative for blood clot. I'm 5'3" and 118lbs. and in excellent health prior to this experience. I feel like the dosage for my size was too much for my body to handle. I need recommendations on how to counteract the adverse effects and/or how long can I expect to feel like this. I am due for the second shot on 4/28/21 and will NOT be taking it. Thank You
side effects; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE DRUG REACTION (side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (side effects). At the time of the report, ADVERSE DRUG REACTION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-066399 (Patient Link).
developed breakthrough Varicella after being vaccinated with VARIVAX; This spontaneous report was received from a physician assistant and refers to a 4 or 5 years old child female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided).  On an unknown date in July 2022, the patient developed breakthrough Varicella after being vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX). The physician assistant reported that the patient was diagnosed at an urgent care and the case was uncomplicated. It was unknown what symptoms the patient experienced.  At the time of reporting, the outcome of breakthrough varicella was not known.   The causal relationship between breakthrough varicella and varicella virus vaccine live (oka/merck) (VARIVAX) was unknown.
I did a rapid test it came back positive. I did a PCR test also, but I am waiting for the result.; chills; muscle pain; mostly fatigue; This is a spontaneous report received from Medical Information and a contactable male consumer (patient). A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and Expiration date not reported), via an unspecified route of administration on 22Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On Monday, 26Apr2021 the patient started feeling symptoms included fatigue, muscle Soreness, that were pretty light. On 27Apr2021, they got worst, the patient had muscle pain and mostly fatigue and in the night, the patient started having chills that are persisting on 28Apr2021. The patient underwent lab tests and diagnosis which include a rapid covid test that came back positive and also got a PCR test but results will not be back for about 48 hours. The outcome of all the events was reported as unknown.  Information about lot/batch number has been requested.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
I developed polymyalgia rheumatica-first symptoms on Feb. 22 but not diagnose until Mar. 30 because of covid. Online contact with clinic did not work until I got an in peron exam and blood test.
BURNING EYES; SORE THROAT; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-MAR-2021, the subject experienced burning eyes. On 14-MAR-2021, the subject experienced sore throat. On 14-MAR-2021, the subject experienced fever. On 14-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, burning eyes, sore throat and headache was not reported. This report was non-serious.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a female patient who received BEXSERO for prophylaxis. Previously administered products included BEXSERO (received 1st dose 6 months prior to 1st dose). On an unknown date, the patient received the 2nd dose of BEXSERO. On an unknown date, unknown after receiving BEXSERO, the patient experienced influenza-like symptoms and drug dose administration interval too long. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved and the outcome of the drug dose administration interval too long was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. At the speaker program the reporter presented at last night, several nurses shared that they had attended a Immunization Conference and were told that BEXSERO should be given at 0 and 6 months so they had been administering BEXSERO on this schedule, which led to lengthening of the vaccination schedule. One of the nurse reported that her daughter experienced flu like symptoms with the second dose of BEXSERO. She did not seem overly concerned and reported that the symptoms resolved. The reporter did not agree to follow up from GlaxoSmithKline. This was 1 of 3 cases reported by the same reporter.